ReviewPubMed ID: 20923259·2010

Thymalfasin: clinical pharmacology and antiviral applications

Tuthill CW, et al.

BioDrugs, 2010

Key finding

Thymosin alpha-1 showed consistent immune-enhancing effects across multiple clinical settings, particularly in hepatitis B.

Summary

Comprehensive review of thymosin alpha-1 clinical data spanning over 100 clinical trials in hepatitis, cancer, and immune deficiency.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

Thymosin Alpha-1L4

A naturally occurring thymic peptide approved internationally for immune modulation, with extensive clinical data in hepatitis and cancer immunotherapy.

More research on Thymosin Alpha-1

COVID-19 immunotherapy: thymosin alpha-1 efficacy in severe disease

Cytokine · 2021 · Human RCT

Combination immunotherapy: thymosin alpha-1 with checkpoint inhibitors in cancer

Journal for ImmunoTherapy of Cancer · 2020 · Human Pilot

Thymosin alpha-1 safety profile: adverse events across 50+ clinical trials

Current Aging Science · 2010 · Review

Thymosin alpha-1 and thymic regeneration in aging

Nature Immunology · 2009 · Animal Study

TNF-α and IL-2 modulation by thymosin alpha-1 in immune cells

Molecular Immunology · 2005 · In Vitro